Healthcare Experts Debate New Methods of Assessing the Value of Prescription Drugs, Medical Devices, and Procedures

Jun 18, 2019

Value in Health, the official journal of ISPOR, the professional society for health economics and outcomes research, announced today the publication of a new supplement, “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare.”

A Beginner’s Guide to Understanding Curative Therapies

Jun 17, 2019

Value in Health, the official journal of ISPOR, the professional society for health economics and outcomes research, announced today the publication of a series of articles offering important insight regarding the current state of curative and transformative therapies.

ISPOR Board of Directors Approves New Diversity and Inclusion Policy

Jun 11, 2019

ISPOR, the professional society for health economics and outcomes research, announced the approval of the Society’s new Diversity and Inclusion Policy.

ISPOR Announces 2019-2020 Board of Directors

Jun 10, 2019

ISPOR, the professional society for health economics and outcomes research, announced the results of its recent elections and its 2019-2020 Board of Directors.

ISPOR 2019 Convened Nearly 4000 Healthcare Stakeholders

May 23, 2019

ISPOR, the professional society for health economics and outcomes research, recently concluded its ISPOR 2019 annual conference in New Orleans, LA, USA.

ISPOR Wins Multiple Hermes Creative Awards

May 23, 2019

ISPOR has won 6 Platinum and Gold level Hermes Awards for its rebranding campaign, website redesign, and “2019 Top 10 HEOR Trends” report.

Patient Access and Biosimilars

May 22, 2019

ISPOR the professional society for health economics and outcomes research, examined the issue of patient access and biosimilars this afternoon at its ISPOR 2019 annual conference.

Is Healthcare Affordability Driving a Need to Revolutionize Drug Pricing?

May 22, 2019

ISPOR, the professional society for health economics and outcomes research, held its final plenary of the ISPOR 2019 annual conference with, “Is Healthcare Affordability Driving a Need to Revolutionize Drug Pricing?”

High Healthcare Costs in the United States—Could Formal Health Technology Assessment Be a Solution?

May 22, 2019

ISPOR, the professional society for health economics and outcomes research, explored the possibility of health technology assessment in the United States this morning at its ISPOR 2019 annual conference ,
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×